Propafenone blocks ATP-sensitive K+ channels in rabbit atrial and ventricular cardiomyocytes

European Journal of Pharmacology

Volumn 373, Issue 2-3, 1999, Pages 223-232

  Christé, Georges ^a   Tebbakh, Habiba ^a   Šimurdová, Milena ^b   Forrat, Rémi ^b   Šimurda, Jirí ^b  

^a INSERM   (France)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Antiarrhythmic; ATP sensitive; Atrium; Cardiomyocyte; K+ channel; Propafenone; Ventricle

Indexed keywords

2,4 DINITROPHENOL; POTASSIUM CHANNEL; PROPAFENONE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEART ATRIUM; HEART MUSCLE CELL; HEART VENTRICLE; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FUNCTION; DINITROPHENOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HEART ATRIA; HEART VENTRICLES; KINETICS; MEMBRANE POTENTIALS; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNEL BLOCKERS; PROPAFENONE; RABBITS; UNCOUPLING AGENTS;

EID: 0032980693     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00217-4     Document Type: Article

References (52)

1. Alekseev A.E., Gomez L.A., Aleksandrova L.A., Brady P.A., Terzic A. Opening of cardiac sarcolemmal KATP channels by dinitrophenol separate from metabolic inhibition. J. Membr. Biol. 157:1997;203-214.
2. Belles B., Hescheler J., Trube G. Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflügers Arch. 409:1987;582-588.
3. + channels suggest multiple targets for inhibitory drug molecules. J. Membr. Biol. 142:1994;309-322.
4. Bryson H.M., Palmer K.J., Langtry H.D., Fitton A. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias. Drugs. 45:1993;85-130.
5. Capucci A., Boriani G. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal. Drug Safety. 12:1995;55-72.
6. Christé, G., Simurdova, M., Tebbakh, H., Forrat, R., Simurda, J., 1997. Therapeutic levels of antiarrhythmic propafenone inhibit ATP-sensitive channels in rabbit myocardial cells. Physiol. Res. 46, 9 pp. (Abstract).
7. 2+ block of ATP-dependent potassium channels of rat skeletal muscle. J. Physiol. (London). 490:1996;817-826.
8. + current by the class Ia agent disopyramide in cat ventricular myocytes. J. Pharmacol. Exp. Ther. 272:1995;714-723.
9. Delgado C., Tamargo J., Tejerina T. Electrophysiological effects of propafenone in untreated and propafenone pretreated guinea-pig atrial and ventricular muscle fibers. Br. J. Pharmacol. 86:1985;765-775.
10. Delgado C., Tamargo J., Henzel D., Lorente P. Effects of propafenone on calcium current in guinea-pig ventricular myocytes. Br. J. Pharmacol. 108:1993;721-727.
11. + current in guinea pig ventricular myocytes. Voltage-independent and time-dependent block of the slowly activating component. Circ. Res. 76:1995;223-235.
12. + channel modification by metabolic inhibition in isolated guinea-pig ventricular myocytes. J. Physiol. (London). 465:1993;163-179.
13. Duan D., Fermini B., Nattel S. Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J. Pharmacol. Exp. Ther. 264:1993;1113-1123.
14. Fei L., Gill J.S., McKenna W.J., Camm A.J. Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig. Br. J. Pharmacol. 109:1993;178-182.
15. + channels in rat ventricular myocytes are blocked and inactivated by internal divalent cations. Pflügers Arch. 410:1987;313-320.
16. + channels during metabolic stress in cardiac muscle. J. Pharmacol. Exp. Ther. 266:1992;456-467.
17. + channels in an operational state. Pflügers Arch. 407:1986;238-240.
18. + channel by MgATP complexes in guinea-pig ventricular myocytes. J. Physiol. (London). 479:1994;95-107.
19. Gross G.J., Auchampach J.A. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70:1992;223-233.
20. Haworth R.A., Goknur A.B., Berkoff H.A. Inhibition of ATP-sensitive potassium channels of adult rat heart cells by antiarrhythmic drugs. Circ. Res. 65:1989;1157-1160.
21. Honjo H., Watanabe T., Kamiya K., Kodama I., Toyama J. Effects of propafenone on electrical and mechanical activities of single ventricular myocytes isolated from guinea-pig hearts. Br. J. Pharmacol. 97:1989;731-738.
22. Horie M., Irisawa H., Noma A. Voltage-dependent magnesium block of adenosine triphosphate-sensitive potassium channels in guinea-pig ventricular cells. J. Physiol. (London). 387:1987;251-272.
23. Horie M., Hayashi S., Yousuke Y., Sasayama S. Comparative studies of ATP sensitive potassium channels in heart and pancreatic β cells using Vaughan-Williams class Ia antiarrhythmics. Cardiovasc. Res. 26:1992;1087-1094.
24. Kakei M., Nakazaki M., Kamisaki T., Nagayama I., Fukamashi Y., Tanaka H. Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic β-cells. Br. J. Pharmacol. 109:1993;1226-1231.
25. Keller K., Meyer-Estorf G., Beck O.A., Hochrein H. Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone. Eur. J. Clin. Pharmacol. 13:1978;17-20.
26. Kishore A.G.R., Camm A.J. Guidelines for the use of propafenone in treating supraventricular arrhythmias. Drugs. 50:1995;250-262.
27. Kohlhardt M. Block of sodium current by antiarrhythmic agents: analysis of the electrophysiologic effects of propafenone in heart muscle. Am. J. Cardiol. 54:1984;13D-19D.
28. max of the action potential by propafenone and its voltage-, time- and pH-dependence in mammalian ventricular myocardium. Arch. Pharmacol. 315:1980;55-62.
29. Krause E., Englert H., Gogelein H. Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim. Pflügers Arch. 429:1995;625-635.
30. Mason J.W. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. New Engl. J. Med. 329:1993;452-458.
31. Németh M., Varro A., Thormahlen D., Papp J.G. Tedisamil is a potent blocker of ATP-sensitive potassium channel in cardiac muscle. Exp. Clin. Cardiol. 2:1997;37-40.
32. ATP channels in guinea-pig ventricular myocytes. J. Physiol. (London). 508(2):1998;401-411.
33. + channels in cardiac muscle. Nature. 305:1983;147-148.
34. Olschewski A., Braü M.E., Olschewski H., Hemplemann M.D., Vogel W. ATP-dependent potassium channel in rat cardiomyocytes is blocked by lidocaine. Circulation. 93:1996;656-659.
35. Opie L.H. Modulation of ischemia by regulation of the ATP-sensitive potassium channel. Cardiovasc. Drugs Ther. 7:1993;507-513.
36. + channels in Xenopus oocytes. Br. J. Pharmacol. 107:1992;1061-1067.
37. + channels in guinea-pig ventricular cells. Br. J. Pharmacol. 108:1993;549-556.
38. + channels. Br. J. Pharmacol. 115:1995;381-382.
39. Shigematsu S., Arita M. Anoxia-induced activation of ATP-sensitive K+ channels in guinea pig ventricular cells and its modulation by glycolysis. Cardiovasc. Res. 35:1997;273-282.
40. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J. Pharmacol. Exp. Ther. 269:1994;66-74.
41. Schoenmakers T.J.M., Visser G.J., Flik G., Theuvenet A.P.R. CHELATOR: an improved method for computing metal ion concentrations in physiological solutions. Biotechniques. 12(6):1992;870-879.
42. + current activated by pinacidil. Circ. Res. 68:1991;1127-1137.
43. Spitzer K.W., Bridge J.H.B. A simple device for rapidly exchanging solution surrounding a single cardiac cell. Am. J. Physiol. 256:1989;C441-C447.
44. + channel. Prog. Neurobiol. 41:1993;21-30.
45. i-sensitive K current. J. Mol. Cell. Cardiol. 29:1997;A120. (Abstract).
46. + channel blocker. Circulation. 90:1994;700-705.
47. ATP and a time-dependent current likely due to potassium accumulation. J. Membr. Biol. 142:1994;337-347.
48. + channels have lower density in human than in rabbit ventricular myocyte. Eur. Heart J. 16:1995;367. Abstract.
49. Verkerk A.O., Veldkamp M.W., Van Ginneken A.C.G., Bouman L.N. Biphasic response of action potential duration to metabolic inhibition in rabbit and human ventricular myocytes: role of transient outward current and ATP-regulated potassium current. J. Mol. Cell. Cardiol. 28:1996;2443-2456.
50. West P.D., Bursill J.A., Wyse K.R., Marin D.K., Campbell T.J. Effect of the class III antiarrhythmic agent E-4031 on the ATP-sensitive potassium channel in rabbit ventricular myocytes. Pharmacol. Toxicol. 78:1996;89-93.
51. Wu B., Sato T., Kiyosue T., Arita M. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea-pig ventricular myocytes by class I antiarrhythmic drugs. Cardiovasc. Res. 26:1992;1095-1101.
52. Yasui K., Anno T., Kamiya K., Boyett M.R., Kodama I., Toyama J. Contribution of potassium accumulation in narrow extracellular spaces to the genesis of nicorandil-induced large inward tail current in guinea-pig ventricular cells. Pflügers Arch. 422:1993;371-379.